261 related articles for article (PubMed ID: 29361432)
1. Research Priorities for Optimizing Geriatric Pharmacotherapy: An International Consensus.
Tan ECK; Sluggett JK; Johnell K; Onder G; Elseviers M; Morin L; Vetrano DL; Wastesson JW; Fastbom J; Taipale H; Tanskanen A; Bell JS;
J Am Med Dir Assoc; 2018 Mar; 19(3):193-199. PubMed ID: 29361432
[TBL] [Abstract][Full Text] [Related]
2. Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper.
van Poelgeest E; Seppala L; Bahat G; Ilhan B; Mair A; van Marum R; Onder G; Ryg J; Fernandes MA; Cherubini A; Denkinger M; Eidam A; Egberts A; Gudmundsson A; Koçak FÖK; Soulis G; Tournoy J; Masud T; Wehling M; van der Velde N;
Eur Geriatr Med; 2023 Dec; 14(6):1195-1209. PubMed ID: 37812379
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy in Older Adults with Cardiovascular Disease: Report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging Workshop.
Schwartz JB; Schmader KE; Hanlon JT; Abernethy DR; Gray S; Dunbar-Jacob J; Holmes HM; Murray MD; Roberts R; Joyner M; Peterson J; Lindeman D; Tai-Seale M; Downey L; Rich MW
J Am Geriatr Soc; 2019 Feb; 67(2):371-380. PubMed ID: 30536694
[TBL] [Abstract][Full Text] [Related]
4. Medication Management in Frail Older People: Consensus Principles for Clinical Practice, Research, and Education.
Liau SJ; Lalic S; Sluggett JK; Cesari M; Onder G; Vetrano DL; Morin L; Hartikainen S; Hamina A; Johnell K; Tan ECK; Visvanathan R; Bell JS;
J Am Med Dir Assoc; 2021 Jan; 22(1):43-49. PubMed ID: 32669236
[TBL] [Abstract][Full Text] [Related]
5. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.
Todd A; Jansen J; Colvin J; McLachlan AJ
BMC Geriatr; 2018 Nov; 18(1):295. PubMed ID: 30497404
[TBL] [Abstract][Full Text] [Related]
6. Inappropriate prescribing: hazards and solutions.
Petrovic M; O'Mahony D; Cherubini A
Age Ageing; 2022 Feb; 51(2):. PubMed ID: 35136899
[TBL] [Abstract][Full Text] [Related]
7. Deprescribing medications in older people: a narrative review.
Salahudeen MS
Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
[TBL] [Abstract][Full Text] [Related]
8. Development of a core outcome set for medication review in older patients with multimorbidity and polypharmacy: a study protocol.
Beuscart JB; Dalleur O; Boland B; Thevelin S; Knol W; Cullinan S; Schneider C; O'Mahony D; Rodondi N; Spinewine A
Clin Interv Aging; 2017; 12():1379-1389. PubMed ID: 28919724
[TBL] [Abstract][Full Text] [Related]
9. Polypharmacy in elderly people.
Dovjak P
Wien Med Wochenschr; 2022 Apr; 172(5-6):109-113. PubMed ID: 35006518
[TBL] [Abstract][Full Text] [Related]
10. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.
McCarthy C; Clyne B; Corrigan D; Boland F; Wallace E; Moriarty F; Fahey T; Hughes C; Gillespie P; Smith SM
Implement Sci; 2017 Aug; 12(1):99. PubMed ID: 28764753
[TBL] [Abstract][Full Text] [Related]
11. [Deprescribing of inappropriate medication in primary care].
Høj K; Mygind A; Livbjerg S; Bro F
Ugeskr Laeger; 2019 Jun; 181(24):. PubMed ID: 31267949
[TBL] [Abstract][Full Text] [Related]
12. Deprescribing in older people.
O'Mahony MS; Parbhoo A
Br J Hosp Med (Lond); 2020 Jan; 81(1):1-9. PubMed ID: 32003625
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based strategies for the optimization of pharmacotherapy in older people.
Topinková E; Baeyens JP; Michel JP; Lang PO
Drugs Aging; 2012 Jun; 29(6):477-94. PubMed ID: 22642782
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing deprescribing habits among geriatricians.
Ní Chróinín D; Ní Chróinín C; Beveridge A
Age Ageing; 2015 Jul; 44(4):704-8. PubMed ID: 25758409
[TBL] [Abstract][Full Text] [Related]
15. Deprescribing for frail older people - Learning from the case of Mrs. Hansen.
Granas AG; Stendal Bakken M; Ruths S; Taxis K
Res Social Adm Pharm; 2018 Jun; 14(6):612-616. PubMed ID: 28733142
[TBL] [Abstract][Full Text] [Related]
16. Polypharmacy and potentially inappropriate medication use in geriatric oncology.
Sharma M; Loh KP; Nightingale G; Mohile SG; Holmes HM
J Geriatr Oncol; 2016 Sep; 7(5):346-53. PubMed ID: 27498305
[TBL] [Abstract][Full Text] [Related]
17. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action.
Mangin D; Bahat G; Golomb BA; Mallery LH; Moorhouse P; Onder G; Petrovic M; Garfinkel D
Drugs Aging; 2018 Jul; 35(7):575-587. PubMed ID: 30006810
[TBL] [Abstract][Full Text] [Related]
18. Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy: a systematic guideline review and expert consensus.
Muth C; Blom JW; Smith SM; Johnell K; Gonzalez-Gonzalez AI; Nguyen TS; Brueckle MS; Cesari M; Tinetti ME; Valderas JM
J Intern Med; 2019 Mar; 285(3):272-288. PubMed ID: 30357955
[TBL] [Abstract][Full Text] [Related]
19. Medication-related problems in older people: how to optimise medication management.
Wong CW
Hong Kong Med J; 2020 Dec; 26(6):510-519. PubMed ID: 33323538
[TBL] [Abstract][Full Text] [Related]
20. Research priorities to address polypharmacy in older adults with cancer.
Nightingale G; Mohamed MR; Holmes HM; Sharma M; Ramsdale E; Lu-Yao G; Chapman A
J Geriatr Oncol; 2021 Jul; 12(6):964-970. PubMed ID: 33589379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
